On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
SABCS is a comprehensive scientific meeting that provides the latest information on prevention, diagnosis, and treatment of breast cancer...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...
Data presented at the AACR Annual Meeting 2016, on April 19, showed that a microdevice about the size of...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...
Guest Post by Virginia Kaklamani, MD, DSc Co-director of the San Antonio Breast Cancer Symposium (SABCS)
Guest post by L. Michelle Bennett, director of the NCI Center for Research Strategies; Worta McCaskill-Stevens, MD, chief of...
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...